Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Senator McCaskill to be absent for three weeks for cancer treatment

Published 02/22/2016, 04:43 PM
Updated 02/22/2016, 04:50 PM
© Reuters. Senator McCaskill (D-MO) of the Senate Commerce, Science and Transportation Subcommittee questions a witness in Washington

WASHINGTON (Reuters) - Senator Claire McCaskill will be absent from Congress for the next three weeks as she undergoes treatment for breast cancer, the Missouri Democrat wrote in a blog post on Monday.

McCaskill, who leads the Senate Special Committee on Aging, said she will post online how she would have voted on any matters that come up during her absence and will submit questions in writing for any missed hearings.

© Reuters. Senator McCaskill (D-MO) of the Senate Commerce, Science and Transportation Subcommittee questions a witness in Washington

"It’s a little scary, but my prognosis is good and I expect a full recovery," McCaskill wrote.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.